NO317112B1 - En fremgangsmate for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder - Google Patents
En fremgangsmate for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder Download PDFInfo
- Publication number
- NO317112B1 NO317112B1 NO19961816A NO961816A NO317112B1 NO 317112 B1 NO317112 B1 NO 317112B1 NO 19961816 A NO19961816 A NO 19961816A NO 961816 A NO961816 A NO 961816A NO 317112 B1 NO317112 B1 NO 317112B1
- Authority
- NO
- Norway
- Prior art keywords
- factor viii
- exhibits
- membrane
- virus
- takes place
- Prior art date
Links
- 108010054218 Factor VIII Proteins 0.000 title claims abstract description 39
- 102000001690 Factor VIII Human genes 0.000 title claims abstract description 39
- 229960000301 factor viii Drugs 0.000 title claims abstract description 39
- 241000700605 Viruses Species 0.000 title claims abstract description 11
- 238000004587 chromatography analysis Methods 0.000 title claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 238000000034 method Methods 0.000 claims abstract description 28
- 230000002779 inactivation Effects 0.000 claims abstract description 10
- 238000011140 membrane chromatography Methods 0.000 claims abstract description 10
- 210000002381 plasma Anatomy 0.000 claims abstract description 6
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims abstract description 4
- 238000009928 pasteurization Methods 0.000 claims abstract description 4
- 238000004090 dissolution Methods 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims description 30
- 239000012528 membrane Substances 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- 239000003446 ligand Substances 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 238000005349 anion exchange Methods 0.000 claims description 7
- 230000002209 hydrophobic effect Effects 0.000 claims description 7
- 238000005342 ion exchange Methods 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 230000003993 interaction Effects 0.000 claims description 5
- 239000003599 detergent Substances 0.000 claims description 4
- -1 poly(glycidyl methacrylates) Polymers 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- 238000000746 purification Methods 0.000 description 9
- 238000010828 elution Methods 0.000 description 8
- 125000006850 spacer group Chemical group 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 238000013375 chromatographic separation Methods 0.000 description 5
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 4
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical group CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N glucosamine group Chemical group OC1[C@H](N)[C@@H](O)[C@H](O)[C@H](O1)CO MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 238000007445 Chromatographic isolation Methods 0.000 description 1
- 102100023804 Coagulation factor VII Human genes 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 108010023321 Factor VII Proteins 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 229940012413 factor vii Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229920002454 poly(glycidyl methacrylate) polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000004094 preconcentration Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical group 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4337573A DE4337573C1 (de) | 1993-11-04 | 1993-11-04 | Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden |
| PCT/EP1994/003258 WO1995012609A1 (de) | 1993-11-04 | 1994-09-30 | Verfahren zur herstellung einer virusinaktivierten faktor viii enthaltenden fraktion mittels chromatographischer methoden |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO961816L NO961816L (no) | 1996-05-03 |
| NO961816D0 NO961816D0 (no) | 1996-05-03 |
| NO317112B1 true NO317112B1 (no) | 2004-08-16 |
Family
ID=6501733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19961816A NO317112B1 (no) | 1993-11-04 | 1996-05-03 | En fremgangsmate for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0726907B1 (xx) |
| JP (1) | JP3739788B2 (xx) |
| KR (1) | KR960705841A (xx) |
| CN (1) | CN1109045C (xx) |
| AT (1) | ATE228533T1 (xx) |
| AU (1) | AU687451B2 (xx) |
| CA (1) | CA2175670C (xx) |
| CZ (1) | CZ290186B6 (xx) |
| DE (2) | DE4337573C1 (xx) |
| ES (1) | ES2182846T3 (xx) |
| FI (1) | FI116569B (xx) |
| HU (1) | HU222087B1 (xx) |
| IL (1) | IL111263A (xx) |
| MY (1) | MY113294A (xx) |
| NO (1) | NO317112B1 (xx) |
| PL (1) | PL181725B1 (xx) |
| RU (1) | RU2148411C1 (xx) |
| SK (1) | SK284215B6 (xx) |
| UA (1) | UA43855C2 (xx) |
| WO (1) | WO1995012609A1 (xx) |
| ZA (1) | ZA948667B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19618851C1 (de) * | 1996-05-10 | 1997-07-24 | Octapharma Ag | Verfahren zur Eignungsprüfung von Faktor VIII-haltigen Proteinfraktionen |
| US6057164A (en) * | 1996-03-08 | 2000-05-02 | Octapharma Ag | Process for testing suitability of protein fractions containing factor VIII |
| ES2137878B1 (es) * | 1997-12-01 | 2000-10-01 | Grifols Grupo Sa | Procedimiento de obtencion de un plasma humano atenuado de virus para uso terapeutico. |
| CN102066417B (zh) | 2008-06-24 | 2015-11-25 | 奥克塔法马股份有限公司 | 提纯凝固因子viii的方法 |
| AU2011343813B2 (en) | 2010-12-15 | 2015-05-21 | Takeda Pharmaceutical Company Limited | Eluate collection using conductivity gradient |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
| DE3432083A1 (de) * | 1984-08-31 | 1986-03-06 | Behringwerke Ag, 3550 Marburg | Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung |
| US5043428A (en) * | 1984-08-31 | 1991-08-27 | Behringwerke Aktiengesellschaft | Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production |
| JPS62191042A (ja) * | 1986-02-17 | 1987-08-21 | Kanegafuchi Chem Ind Co Ltd | 血液凝固第８因子吸着体およびそれを用いた血液凝固第８因子の精製法 |
| CA1339946C (en) * | 1987-03-31 | 1998-07-07 | Michael J. Griffith | Ultrapurification process for polypeptides |
| US4774323A (en) * | 1987-06-29 | 1988-09-27 | Rorer Pharmaceutical Corporation | Purification of von Willebrand Factor solutions using gel permeation chromatography |
| US4795806A (en) * | 1987-07-16 | 1989-01-03 | Miles Laboratories, Inc. | Phospholipid affinity purification of Factor VIII:C |
| CA2001720C (en) * | 1988-10-31 | 2001-10-02 | Randal A. Goffe | Membrane affinity apparatus and purification methods related thereto |
| EP0367840B1 (de) * | 1988-11-05 | 1993-02-03 | Octapharma AG | Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie |
| CH678155A5 (xx) * | 1989-08-09 | 1991-08-15 | Fischer Ag Georg | |
| AT399818B (de) * | 1992-04-24 | 1995-07-25 | Immuno Ag | Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation |
-
1993
- 1993-11-04 DE DE4337573A patent/DE4337573C1/de not_active Revoked
-
1994
- 1994-09-30 KR KR1019960702337A patent/KR960705841A/ko not_active Application Discontinuation
- 1994-09-30 UA UA96041756A patent/UA43855C2/uk unknown
- 1994-09-30 JP JP51297795A patent/JP3739788B2/ja not_active Expired - Fee Related
- 1994-09-30 AU AU78109/94A patent/AU687451B2/en not_active Expired
- 1994-09-30 CZ CZ19961187A patent/CZ290186B6/cs not_active IP Right Cessation
- 1994-09-30 PL PL94314185A patent/PL181725B1/pl not_active IP Right Cessation
- 1994-09-30 RU RU96110890A patent/RU2148411C1/ru not_active IP Right Cessation
- 1994-09-30 DE DE59410213T patent/DE59410213D1/de not_active Expired - Lifetime
- 1994-09-30 HU HU9601192A patent/HU222087B1/hu not_active IP Right Cessation
- 1994-09-30 ES ES94928846T patent/ES2182846T3/es not_active Expired - Lifetime
- 1994-09-30 CN CN94194020A patent/CN1109045C/zh not_active Expired - Fee Related
- 1994-09-30 SK SK566-96A patent/SK284215B6/sk not_active IP Right Cessation
- 1994-09-30 CA CA002175670A patent/CA2175670C/en not_active Expired - Fee Related
- 1994-09-30 WO PCT/EP1994/003258 patent/WO1995012609A1/de active IP Right Grant
- 1994-09-30 AT AT94928846T patent/ATE228533T1/de active
- 1994-09-30 EP EP94928846A patent/EP0726907B1/de not_active Expired - Lifetime
- 1994-10-12 IL IL11126394A patent/IL111263A/xx not_active IP Right Cessation
- 1994-11-03 ZA ZA948667A patent/ZA948667B/xx unknown
- 1994-11-03 MY MYPI94002921A patent/MY113294A/en unknown
-
1996
- 1996-05-03 FI FI961900A patent/FI116569B/fi active IP Right Grant
- 1996-05-03 NO NO19961816A patent/NO317112B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8062848B2 (en) | Nucleic acid-free thermostable enzymes and methods of production thereof | |
| RU2025129C1 (ru) | Способ получения концентрата фактора viii и фактора фон виллебранда | |
| US6960463B2 (en) | Separation of fibrinogen from plasma proteases | |
| US5071961A (en) | Method of enrichment of coagulation factors ii, vii, ix and x | |
| NO317112B1 (no) | En fremgangsmate for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder | |
| US7811807B2 (en) | Nucleic acid purification | |
| EP0733104B1 (en) | Purification of vitamin-k dependent proteins by membrane chromatography | |
| Cocucci et al. | Co-sedimentation of one form of plasma membrane H+-ATPase and of the fusicoccin receptor from radish microsomes | |
| JPS63132898A (ja) | 蛋白質の分離精製方法 | |
| JPS6020998B2 (ja) | 高活性固定化グルコ−スイソメラ−ゼの効率的製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |